Why could no foreign pharmaceutical company manufacture a COVID vaccine in India? The Minister of Health responds for the first time
New Delhi: Speaking at the launch of Priyam Gandhi-Mody’s book ‘A Nation to Protect: Leading India Through the Covid Crisis’, Union Health Minister Mansukh Mandaviya revealed how India has refused to s bow to foreign vaccine companies during the peak of the COVID -19 pandemic. Mandaviya was responding to a question from Zee News editor Sudhir Chaudhury at the book’s launch event when he revealed how Pfizer and Moderna were making unreasonable demands to supply India with vaccines during the crisis.Read also – Study explains how severity of Covid-19 affects gut health
“Major vaccine manufacturing companies like Moderna and Pfizer saw India as a huge market for their drugs and they never thought that India would be able to immunize its population of over 1.16 crore on its own, said the Ministry of Health. However, India has not only been able to manufacture its own coronavirus vaccine but also export it to other countries,” he said. Also Read – With COVID wave diminishing, Odisha, Goa among other states are removing additional curbs. Check details here
The book, which is an account of the government and people of India dealing with the notorious virus and its inflictions, was launched by Mandaviya with Prof. Shamika Ravi (Economist) and Dr. VK Paul (NITI Aayog member). In a follow-up discussion moderated by Zee News editor Sudhir Chaudhary, who was managing the book launch event, asked the Minister of Health why no foreign pharmaceutical companies were able to enter India during the pandemic. of coronavirus to which Dr. Mandaviya made the above observations. So far, the Ministry of Health has only given diplomatic answers to this question, but for the first time ever, the Union Minister has expanded on the issue. Also Read – ‘Omicron-led third wave of COVID has set in’: Niti Aayog’s VK Paul urges all not to let their guard down
Tried to capture India’s response from an outsider’s perspective: Mody
The discussion also saw Priyam Gandhi-Mody and the distinguished panel talk about aspects of India’s fight against the pandemic. “I could see the situation from top to bottom,” Priyam Gandhi-Mody said of her book. Asked about her approach, she said she tried to capture India’s response to the pandemic from an outsider’s perspective.
In his opening address, Gandhi-Mody noted that doomsday predictions have been made about India all over the world. “It has been said that because of India, the global Covid response will take a hit,” she said. She expressed her displeasure with the “political partisanship” that was seen in India’s political arena just as Prime Minister Narendra Modi was leading the country out of the grip of the pandemic.
Sudhir Chaudhary noted that some of the media were trying to take advantage of the frenzy to target the establishment. “Do you think they did the nation a disservice through their cover?” Chaudhary asked. “It’s often said that ‘sadness is sexy’. But how sexy is it if you’re going to do it at the expense of your country?” replied Gandhi-Mody. ‘us versus them’ battle,” she added.
“A nation to protect” describes the reality of the last 2 years: Mandaviya
Union Minister Mansukh Mandaviya said he believed “One Nation to Protect” describes the reality as it has unfolded over the past two years. “We have seen what happens when there is real leadership with a vision,” Mandaviya said in reference to Prime Minister Modi.
“PM Modi is a very good listener,” said NITI Aayog member Dr. VK Paul. “I’m often surprised at his ability to read a lot,” said Professor Shamika Ravi, the economist who served as a member of the Prime Minister’s Economic Advisory Council.
“So do you think Covid is man-made?” Sudhir Chaudhary asked Priyam Gandhi-Mody towards the end of the session. She said she would like more information to come out. “A Nation to Protect” was published by Rupa Publications.
The two vaccines, which were widely used to immunize the Indian population during the three waves of the pandemic – Covishield and Covaxin – were manufactured here only. The Center has licensed two other foreign vaccines – the Russian Sputnik vaccine and Johnson & Johnson’s single-dose vaccine – which are also manufactured by Indian pharmaceutical companies.